Effects of Conbercept on different optical coherence tomography biomarkers in patients with retinal vein occlusion-related macular edema
10.3980/j.issn.1672-5123.2025.10.19
- VernacularTitle:康柏西普对视网膜静脉阻塞性黄斑水肿患者不同OCT生物标记物的影响
- Author:
Haiyue YU
1
;
Juan TENG
1
;
Zeying DONG
1
;
Lili ZHANG
1
;
Huixian CUI
1
;
Chang LIU
1
;
Guang ZHU
1
;
Xin LI
1
Author Information
1. Department of Ophthalmology, Bengbu Municipal Second People Hospital, Bengbu 233000, Anhui Province, China
- Publication Type:Journal Article
- Keywords:
retinal vein occlusion;
macular edema;
Conbercept;
swept source-optical coherence tomography(OCT);
ellipsoid zone
- From:
International Eye Science
2025;25(10):1656-1661
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To investigate the effects of Conbercept on various optical coherence tomography(OCT)biomarkers in patients with retinal vein occlusion-related macular edema(RVO-ME), and to analyze the correlation of these biomarker changes with visual prognosis.METHODS: Retrospective study. A total of 57 patients(57 eyes)with RVO-ME, including 25 patients(25 eyes)with central retinal vein occlusion(CRVO)and 32 patients(32 eyes)with branch retinal vein occlusion(BRVO), were enrolled in this study. All the patients received intravitreal injection of conbercept once a month, three times in total. The preoperative and postoperative best-corrected visual acuity(BCVA), and changes in OCT biomarkers, including central macular thickness(CMT), the length of disorganization of the retinal inner layers(DRIL), the number of hyperreflective dots(HRD), the area of intraretinal fluid(IRF), the area of subretinal fluid(SRF), and the length of ellipsoid zone(EZ)disruption were compared. Furthermore, the relationship of these changes with BCVA was analyzed.RESULTS:Compared with the baseline, at 3 mo post-treatment, BCVA(LogMAR)was improved, CMT was decreased, the length of DRIL was shortened, the number of HRD was reduced, the area of IRF was decreased, the area of SRF was reduced, and the length of EZ disruption was shortened(all P<0.05). Spearman correlation analysis showed that there was no correlation between the changes in CMT, the length of DRIL, the number of HRD, the area of IRF, the area of SRF and the change in BCVA before and after treatment(P>0.05). However, the change in the length of EZ disruption was positively correlated with the change in BCVA(rs=0.34, P=0.011), and the R2 value of the fitting curve between the change in the length of EZ disruption and the change in BCVA was 0.113(P=0.011). When comparing the pre- and post-treatment changes in BCVA, the length of DRIL, the number of HRD, the area of IRF, the area of SRF, and the length of EZ disruption between patients in the CRVO group and BRVO group, no significant differences were observed(all P>0.05). In contrast, a significant difference was found in the change in CMT between the two groups(P=0.002).CONCLUSION:Conbercept effectively improves multiple OCT biomarkers in patients with RVO-ME. Repair of EZ disruption is a key driver of visual recovery, and its stability may serve as a novel indicator for personalized decision-making in anti-vascular endothelial growth factor therapy.
